Members |
targetComponentId |
Dermatosis attributable to coumarin anticoagulant |
Dermatosis caused by coumarin (disorder) |
Dermatosis of suspected viral etiology |
Viral infection of skin suspected |
Dermatosis resulting from immunosuppressive therapy |
Dermatosis caused by immunosuppressant |
Deroofing of cyst of organ NOC |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
Desflurane 99% liquid |
Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Desloratadine 0.5mg/mL syrup |
Product containing precisely desloratadine 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
Desloratadine 2.5mg/pseudoephedrine 120mg m/r tablet |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
Desloratadine 2.5mg/pseudoephedrine 120mg prolonged-release oral tablet |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
Desloratadine 5mg/pseudoephedrine 240mg m/r tablet |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
Desloratadine 5mg/pseudoephedrine 240mg prolonged-release oral tablet |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
Desmoplastic fibroma |
Desmoplastic fibroma |
Desmoplastic juvenile ganglioglioma |
Desmoplastic infantile astrocytoma |
Desmopressin acetate 0.01% solution |
Product containing only desmopressin (medicinal product) |
Desoximetasone 0.5% gel |
Product containing only desoximetasone (medicinal product) |
Destruction of intervertebral disc by other specified method |
Vertebral column destructive procedure |
Destruction of lesion NOS |
Destruction of lesion |
Destruction of lesion NOS |
Destruction of lesion |
Destruction of lesion of female perineum |
Destruction of lesion of perineum |
Destruction of lesion of female perineum NEC |
Destruction of lesion of perineum |
Destruction of lesion of organ NOC NOS |
Destruction of lesion |
Destruction of lesion of organ NOC OS |
Destruction of lesion |
Destruction of tissue of heart |
Catheter ablation of tissue of heart |
Destruction of tissue of pharynx |
Pharynx destructive procedure |
Destructive procedure of facial bone |
Facial bone destructive procedure |
Destructive procedure on fetus to facilitate delivery |
Destruction of fetus |
Desulfotomaculum orientis |
Desulfosporosinus orientis |
Detachment of left retina co-occurrent with retinal defect |
Detachment of left retina with retinal break |
Detachment of right retina co-occurrent with retinal defect |
Detachment of right retina with retinal break |
Detection of poison |
Measurement of substance (procedure) |
Detrusor hyperreflexia of bladder |
Neurogenic detrusor overactivity |
Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
Detrusor instability of bladder |
Idiopathic detrusor overactivity (disorder) |
Developmental handicap screening |
Screening for developmental disorder (procedure) |
Dexamethasone 0.5mg/5mL elixir |
Dexamethasone 100 microgram/mL oral solution |
Dexamethasone sodium phospha 0.05% |
Dexamethasone only product in ocular dose form |
Dexamethasone sodium phosphate 0.05% conventional release eye drops |
Dexamethasone only product in ocular dose form |
Dexamethasone sodium phosphate 0.05% single-use eye drops |
Dexamethasone only product in ocular dose form |
Dexamethasone+hypromellose 0.1%/0.5% eye drops |
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
Dexamfetamine - non-pharmaceutical |
Dexamfetamine |
Dexlansoprazole 30mg dual delayed-release oral capsule |
Dexlansoprazole 30 mg gastro-resistant oral capsule |
Dexlansoprazole 30mg m/r capsule |
Dexlansoprazole 30 mg gastro-resistant oral capsule |
Dexlansoprazole 60mg dual delayed-release oral capsule |
Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Dexlansoprazole 60mg m/r capsule |
Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Dexmethylphenidate 20mg m/r capsule |
Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug) |
Dexmethylphenidate 20mg prolonged-release oral capsule |
Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug) |
Dexmethylphenidate 5mg m/r capsule |
Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule |
Dexmethylphenidate 5mg prolonged-release oral capsule |
Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule |
Dexon patch |
Prosthetic patch |
Dexon suture |
Polyglycolic acid suture |
Dexrazoxane hydrochloride |
Product containing dexrazoxane (medicinal product) |
Dextran 40 (10%) injection solution 500mL bottle |
Dextran 40 100 mg/mL solution for injection |
Dextran 40 10% injection |
Dextran 40 100 mg/mL solution for injection |
Dextran 40/dextrose 5% infusion solution bag |
Dextran 40 100 mg/mL solution for injection |
Dextran 40/sodium chloride 0.9% infusion solution bag |
Dextran 40 100 mg/mL solution for injection |
Dextran 70 in sodium chloride 7.5% infusion |
Dextran 70 only product in parenteral dose form |
Dextran 70 in sodium chloride 7.5% infusion solution |
Dextran 70 only product in parenteral dose form |
Dextran 70/dextrose 5% infusion solution bag |
Dextran 70 only product in parenteral dose form |
Dextran 70/sodium chloride 0.9% infusion solution bag |
Dextran 70 only product in parenteral dose form |
Dextran allergy |
Non-allergic hypersensitivity to dextran (finding) |
Dextroamphetamine sulfate 10mg m/r capsule |
Dexamfetamine only product in oral dose form |
Dextroamphetamine sulfate 10mg prolonged-release oral capsule |
Dexamfetamine only product in oral dose form |
Dextroamphetamine sulfate 15mg m/r capsule |
Dexamfetamine only product in oral dose form |
Dextroamphetamine sulfate 15mg prolonged-release oral capsule |
Dexamfetamine only product in oral dose form |
Dextroamphetamine sulfate 5mg m/r capsule |
Dexamfetamine only product in oral dose form |
Dextroamphetamine sulfate 5mg prolonged-release oral capsule |
Dexamfetamine only product in oral dose form |
Dextromethorphan 7.5mg pastille |
Dextromethorphan 7.5 mg oromucosal lozenge |
Dextromethorphan hydrobromide + promethazine hydrochloride 15mg/6.25mg liquid |
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
Dextromethorphan hydrobromide 6.67mg/5mL syrup |
Dextromethorphan hydrobromide 1.33 mg/mL oral solution |
Dextromethorphan hydrobromide 7.5mg/5mL oral elixir |
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Dextromethorphan hydrobromide 7.5mg/5mL syrup |
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Dextromethorphan hydrobromide allergy |
Allergy to dextromethorphan |
Dextrose + lidocaine hydrochloride 7.5%ww/1.5%ww injection |
Lidocaine only product in parenteral dose form |
Dextrose 10% solution |
Product containing only glucose (medicinal product) |
Dextrose 20% solution |
Product containing only glucose (medicinal product) |
Dextrose 25% solution |
Product containing only glucose (medicinal product) |
Dextrose 30% solution |
Product containing only glucose (medicinal product) |
Dextrose 40% solution |
Product containing only glucose (medicinal product) |
Dextrose 60% in water conventional release solution for infusion 1000mL bag |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrose 60% in water conventional release solution for infusion 500mL bag |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrose 60% in water intravenous solution 1000mL bag |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrose 60% in water intravenous solution 500mL bag |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrose 60% solution |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrose 60g injection |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrose 7.5%ww/lidocaine hydrochloride 1.5%ww injection solution vial |
Lidocaine only product in parenteral dose form |
Dextrose 70% solution |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrothyroxine sodium allergy |
Allergy to dextrothyroxine (finding) |
DiGeorge sequence |
A rare chromosomal anomaly which causes a congenital malformation disorder that is typically characterized by cardiac defects, palatal anomalies, facial dysmorphism, developmental delay and immune deficiency. |
DiGeorge syndrome |
A rare chromosomal anomaly which causes a congenital malformation disorder that is typically characterized by cardiac defects, palatal anomalies, facial dysmorphism, developmental delay and immune deficiency. |
Diabetes care by hospital only |
Diabetic monitoring status |
Diabetes care by hospital only |
Diabetic monitoring status |
Diabetes care by hospital only |
Diabetic monitoring status |
Diabetes care plan agreed |
Agreeing on diabetes care plan (procedure) |
Diabetes clinical management plan |
Diabetes clinical management plan |
Diabetes mellitus associated with unlisted condition |
Diabetes mellitus |
Diabetes mellitus caused by non-steroid drugs without complication |
Diabetes mellitus induced by non-steroid drugs |
Diabetes mellitus with no mention of complication |
Diabetes mellitus |
Diabetes mellitus with no mention of complication |
Diabetes mellitus |
Diabetes mellitus without complication |
Diabetes mellitus |
Diabetes self management plan |
Diabetes self management plan (record artifact) |